News Home » Medical and Pharma » Roche to seize leap-frog opportunity in lung cancer

Around the World

Roche to seize leap-frog opportunity in lung cancer

James Bay 3 December 6, 2017
After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer.